Immune Checkpoint Inhibitor Toxicities
Practical knowledge and skills are required to manage the needs of the growing patient population treated with ICIs, particularly as our understanding of best practices for addressing complex toxicities evolves.
  • Management of Immunotherapy-Related Toxicities
  • Enduring Activity
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation